Journal · Diabetes · Updated 21 November 2026
Diabetologia
Read Diabetologia articles on DeepDyve. No university library needed.
Diabetologia has published since 1965 and covers diabetes research, from type 1 and type 2 diabetes and their treatment to related conditions such as fatty liver disease. It’s an official journal of the European Association for the Study of Diabetes, published by Springer Nature. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.
Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.
Personal plans aren’t for business use. Reading for work? See Enterprise.
Diabetologia at a glance
- Full title
- Diabetologia
- Abbreviation (NLM)
- Diabetologia
- Publisher
- Springer Nature
- Print ISSN
- 0012-186X
- Online ISSN (eISSN)
- 1432-0428
- First published
- 1965
- Subjects
- Endocrinology
- Access model
- Hybrid (67% free to read in 2026)
Ways to access Diabetologia
67% of the articles Diabetologia published from January 1 to November 19, 2026 are open access and free to read. For the rest, look for the authors’ manuscript, check a library, or read them on DeepDyve.
- Open access articles. 67% of Diabetologia articles published from January 1 to November 19, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
- The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication.
- Ask the authors. Authors can also share a free, read-only link to their published article through Springer Nature’s SharedIt, so it’s worth asking the authors directly.
- NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
- A library. Your university, hospital or public library may subscribe to Diabetologia. Check its journal list and whether it offers remote access.
- DeepDyve. Read Diabetologia articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.
Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.
Impact factor and metrics
Diabetologia’s 2025 Journal Impact Factor is 10.4, and its 5-year Impact Factor is 10.3.
10.4
Journal Impact Factor (2025)
10.3
5-year Impact Factor (2025)
8.7M
Downloads (2025)
Source: journal metrics on the Diabetologia homepage (Springer Nature), checked November 21, 2026. Impact Factor from Clarivate Journal Citation Reports.
Recent Diabetologia research worth reading
Published January to June 2026. Summaries describe what the authors report.
-
Teplizumab treatment for stage 2 type 1 diabetes: a real-world evaluation of metabolic and immunological outcomes
Following 30 people with stage 2 type 1 diabetes treated with teplizumab in routine care, the authors report improved 2-hour glucose and HbA1c at 2 to 6 months and a fall in T cells targeting preproinsulin, which they suggest may serve as biomarkers.
Karakus et al. · Diabetologia, published online January 15, 2026 · DOI 10.1007/s00125-025-06646-6
-
Metabolic drivers of MASLD and MASH: from hormonal imbalance to fibrosis
The authors review how insulin resistance, an imbalance of insulin and glucagon, and crosstalk between fat tissue and the liver drive metabolic dysfunction-associated steatotic liver disease toward inflammation and fibrosis.
Gastaldelli et al. · Diabetologia, published online June 20, 2026 · DOI 10.1007/s00125-026-06774-7
-
Subtypes of newly diagnosed type 2 diabetes and risk of complications: analysis of electronic health records in the USA
Using electronic health records of 727,076 US adults with newly diagnosed type 2 diabetes, Li and colleagues report that people classified as having severe insulin-deficient diabetes had higher hazard ratios for retinopathy (HR 2.83), neuropathy, nephropathy and heart failure than those with mild obesity-related diabetes.
Li et al. · Diabetologia, published online February 21, 2026 · DOI 10.1007/s00125-026-06687-5
-
Maternal pre-pregnancy BMI differentially regulates intracellular pH in human umbilical vein endothelium from gestational diabetes mellitus pregnancies, with alkalinisation-associated reduction of adenosine transport in normal weight pregnancies
In umbilical vein endothelial cells from 43 normal and 23 gestational diabetes pregnancies, Fuentes and colleagues report that gestational diabetes was linked to intracellular alkalinisation of about 0.6 pH units, with effects on pH regulation varying by the mother’s pre-pregnancy BMI.
Fuentes et al. · Diabetologia, published online February 24, 2026 · DOI 10.1007/s00125-026-06679-5
-
Sex steroids, SHBG and type 2 diabetes in women: what do we really know?
Verhoog and colleagues review how androgens, oestrogens and their carrier protein sex hormone-binding globulin (SHBG) affect type 2 diabetes in women, noting that SHBG itself plays a role in diabetes risk independent of the sex steroids it carries.
Verhoog et al. · Diabetologia, published online January 15, 2026 · DOI 10.1007/s00125-025-06647-5
Related journals
Questions about Diabetologia
How can I read Diabetologia articles without a subscription?
67% of Diabetologia articles published from January 1 to November 19, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication. Your library may also subscribe. DeepDyve lets you read Diabetologia articles online for $59 a month or $499 a year after a free first month.
What is the abbreviation for Diabetologia?
Diabetologia isn’t abbreviated: its NLM (PubMed) abbreviation is simply Diabetologia.
What is the ISSN of Diabetologia?
The print ISSN is 0012-186X and the online ISSN is 1432-0428.
What is the impact factor of Diabetologia?
Diabetologia’s Journal Impact Factor is 10.4 (2025), and its 5-year Impact Factor is 10.3, according to Springer Nature’s published metrics.
Is Diabetologia open access?
Diabetologia is a hybrid journal: authors can choose to publish open access or under the subscription model. From January 1 to November 19, 2026, 175 of 262 Diabetologia articles (67%) carry a Creative Commons license, per Crossref.
Diabetologia articles on DeepDyve are licensed from Springer Nature. Journal facts as of 21 November 2026.
Start reading Diabetologia today
One month free, then less than $2 a day. Diabetologia, plus millions of articles from thousands of journals.





